Civil Hospices of Lyon
Activated clotting time (ACT) is currently recommended to monitor high concentrations heparin anticoagulation. ACT-LR was specifically designed to measure the activity of low dose of heparin used during endovascular surgery. The correlation between ACT-LR and Anti Xa activity which is considered as the gold standard seems to be debated. Few studies in literature had shown controversial results. These studies were conducted in patients who underwent open as endovascular surgery. However, the ACT monitoring is not recommended in open surgery. In addition, heparin administration protocols are not described and specific to each centre. In this study investigators want to study the correlation between LR-ACT and anti Xa after introducing a heparin protocol during complex endovascular procedures.
Aortic Diseases
Arterial Disease
Thrombosis
Anti Xa activity measurement.
| Study Type : | Observational |
| Estimated Enrollment : | 150 participants |
| Official Title : | Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. |
| Actual Study Start Date : | November 2022 |
| Estimated Primary Completion Date : | November 2024 |
| Estimated Study Completion Date : | November 2024 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Vascular surgery department (U50) Louis Pradel Hospital - HCL
Bron, France, 69500